B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 5 360 KRW -1.29% Market Closed
Market Cap: 547B KRW

Wall Street
Price Targets

Price Targets Summary
BioNote Inc

There are no price targets for BioNote Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
BioNote Inc Competitors:
Price Targets
SYNACT
SynAct Pharma AB
19% Upside
TLX
Telix Pharmaceuticals Ltd
141% Upside
9966
Alphamab Oncology
7% Downside
ARWR
Arrowhead Pharmaceuticals Inc
2% Downside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
9% Upside
EXEL
Exelixis Inc
5% Upside
BSLN
Basilea Pharmaceutica AG
40% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
45% Upside

Revenue
Forecast

Revenue Estimate
BioNote Inc

For the last 4 years the compound annual growth rate for BioNote Inc's revenue is -36%. The projected CAGR for the next 2 years is 38%.

-36%
Past Growth
38%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
BioNote Inc

For the last 4 years the compound annual growth rate for BioNote Inc's operating income is -62%. The projected CAGR for the next 2 years is 39%.

-62%
Past Growth
39%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
BioNote Inc

For the last 4 years the compound annual growth rate for BioNote Inc's net income is -43%. The projected CAGR for the next 2 years is -24%.

-43%
Past Growth
-24%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BioNote Inc's stock price target?
Not Available

BioNote Inc doesn't have any price targets made by Wall Street professionals.

What is BioNote Inc's Revenue forecast?
Projected CAGR
38%

For the last 4 years the compound annual growth rate for BioNote Inc's revenue is -36%. The projected CAGR for the next 2 years is 38%.

What is BioNote Inc's Operating Income forecast?
Projected CAGR
39%

For the last 4 years the compound annual growth rate for BioNote Inc's operating income is -62%. The projected CAGR for the next 2 years is 39%.

What is BioNote Inc's Net Income forecast?
Projected CAGR
-24%

For the last 4 years the compound annual growth rate for BioNote Inc's net income is -43%. The projected CAGR for the next 2 years is -24%.

Back to Top